Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
03:32pMY SIZE : April, 2018 | My Size Identifies Growing E-Commerce Platform Market as Key Opportunity for Mass Adoption of MySizeID Mobile Measurement Technology
PU
03:31pREGENERON PHARMACEUTICALS : Announces Upcoming Investor Conference Presentations
PR
03:31pArcturus Therapeutics Founder Joseph Payne Dismisses Board’s Baseless Lawsuit as Desperate Entrenchment Tactic
GL
03:30pCOGENTIX MEDICAL : LABORIE Medical Technologies and Cogentix Medical Announce Completion of Acquisition of Cogentix Medical by LABORIE Medical Technologies
AQ
03:30pIMMURON : Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets
AQ
03:30pUPDATE -- Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting
GL
03:24pBIOTRICITY INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
03:21pILLUMINA : Update: Lawsuit for Investors in Illumina, Inc. (NASDAQ: ILMN) Shares Announced by Shareholders Foundation
AC
03:20pNutritional High to Acquire 100% of California-Based Extraction Company
GL
03:18pCANCER GENETICS INC : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX
AC
03:11pACADIA PHARMACEUTICALS : PMDAlliance and ACADIA Pharmaceuticals Survey Reveals Serious Quality-of-Life Impact of Non-Movement Symptoms of Parkinson’s Disease
BU
03:07pMEDICAL FACILITIES : Compliance and business integrity (cbi) audits and claims analysis services for the veterans integrated service network (visn) 16 medical facilities
AQ
03:07pVAREX IMAGING CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
03:03pACCELERATE DIAGNOSTICS : 65VII) 65VII Diagnostic, Reagents, Test Kits & Sets
AQ
03:02pBOSTON SCIENTIFIC : 65-- 506 - boston# 1698 - pre surgery defib procedure on 4-17-18 - pt ien# 239692 - ien# 786663 (va-18-00074820)
AQ
03:02pNEL ASA : Receives Additional Purchase Order from Nikola
AQ
03:01pCEAPRO INC. : Provides Corporate Update
AQ
03:01pSIENNA SENIOR LIVING : Announces Redemption of Extendible Convertible Unsecured Subordinated Debentures
AQ
03:01pABBOTT LABORATORIES : Sanquin Selects Abbott's "Alinity™ s" Solution for Blood and Plasma Screening
PR
02:52pSHIRE : Form 8.3 -
PU
02:50pNANOSTRING TECHNOLOGIES : Notice of Intent for Sole Source for nCounter Analysis System
AQ
02:46pMY SIZE : Identifies Growing E-Commerce Platform Market as Key Opportunity for Mass Adoption of MySizeID Mobile Measurement Technology
PR
02:45pAZURRX BIOPHARMA : and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)
AQ
02:44pAKORN : Asks Delaware Court to Require Fresenius Kabi to Fulfill Its Obligations under Merger Agreement
BU
02:43pPREMIER INC. : Sets May 7 for Fiscal 2018 Third-Quarter Financial Results and Conference Call
BU
02:37pINVESCO LTD. : Form 8.3 - Shire PLC
PU
02:35pELEVEN BIOTHERAPEUTICS INC : Today's Research Reports on Trending Tickers: Eleven Biotherapeutics and CVS Health
AC
02:33pTEVA PHARMACEUTICAL INDUSTRIES : to Report First Quarter 2018 Financial Results on May 3, 2018
BU
02:32pAMERICANN INC : AmeriCann CEO Tim Keogh to Present at Rocky Mountain MicroCap Conference II to Be Held in Denver, Colorado on April 24, 2018
AC
02:32pOptimizeRx Partners with EvidenceCare to Deliver Real-time Medication Messaging to Hospitals
GL
02:31pINTEGER : Metropolitan Life Insurance Co. NY Sells 11,465 Shares of Integer Holdings (ITGR)
AQ
02:31pMEDTRONIC : ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement
AQ
02:31pALDER BIOPHARMACEUTICALS : reg; Appoints Eric Carter, Ph.D., M.D., as Interim Chief Medical Officer
AQ
02:31pPROFOUND MEDICAL : Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales and Marketing Function
AQ
02:31pIntellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting
GL
02:31pSTERIS : Varex Imaging Names Rosebrough To Board Of Directors
PR
02:31pSarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Devel-opments on May 3, 2018
GL
02:31pUltragenyx Announces Filing and FDA Clearance of an Investigational New Drug Application for DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia
GL
02:25pFORTRESS BIOTECH : Caelum Biosciences Submits Draft Registration Statement on Form S-1 to the Securities and Exchange Commission
AQ
02:25pACCELERATE DIAGNOSTICS : announces sizeable release of new data at ECCMID 2018
AQ
02:21pCambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility
GL
02:16pAbeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
GL
02:16pABEONA THERAPEUTICS : Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
GL
02:13pEISAI : Rights to Non-Opioid Severe Chronic Pain Treatment Prialt Transferred to Riemser
AQ
02:10pLABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
AQ
02:10pPROTEOSTASIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
02:08pPFIZER : Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years
BU
02:07pPFIZER : Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years
PU
02:07pMERCK : Life Science Business of Merck KGaA, Darmstadt, Germany Receives Patent for CRISPR Technology in China
PU
02:07pTHERMO FISHER SCIENTIFIC : Announces $50 Million Investment to Enhance Biologics Capabilities
PU
02:07pCTD HOLDINGS CLOSES $2.00 MILLION PRIVATE PLACEMENT APR 23, 2018, 8 : 00 am edt
PU
02:07pTRACON PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
02:05pACETO CORP : Other Events (form 8-K)
AQ
02:03pADVAXIS : Announces Executive Leadership Changes
BU
02:02pAchaogen Highlights Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
GL
02:01pCTD : Closes $2.00 Million Private Placement
AQ
02:01pFULGENT GENETICS : to Announce First Quarter 2018 Financial Results on Monday May 7, 2018
AQ
02:01pCATALYST BIOSCIENCES : Announces Presentation at the 2018 Association for Research in Vision and Ophthalmology Annual Meeting
AQ
02:01pSPECTRAL MEDICAL : Completes $5.3 Million Financing
AQ
02:01pSorrento Therapeutics CEO Dr. Henry Ji Invited to the Fourth International Vatican Conference on “Unite to Cure”
GL
1  2  3  4  5  6  7  8  9  10Next
Advertisement